Journal of Pathology J Pathol 2018; 244: 265–270 BRIEF DEFINITIVE REPORT Published online 1 February 2018 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/path.5012 Donor-derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus David C Müller1,2† , Maarit Rämö1,2†, Klaudia Naegele3, Sebastian Ribi2, Christian Wetterauer1, Valeria Perrina2, Luca Quagliata2, Tatjana Vlajnic2, Christian Ruiz2, Beate Balitzki4, Rainer Grobholz5, Rainer Gosert3, Elvis T Ajuh6, Hans H Hirsch3,6‡, Lukas Bubendorf2‡ and Cyrill A Rentsch1*‡ 1 Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland 2 Institute for Pathology, University Hospital Basel, University of Basel, Basel, Switzerland 3 Division of Infection Diagnostics, Department of Biomedicine, University of Basel, Basel, Switzerland 4 Institute of Forensic Medicine, University of Basel, Basel, Switzerland 5 Institute for Pathology, Kantonsspital Aarau, Switzerland 6 Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland *Correspondence to: CA Rentsch, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland. E-mail:
[email protected] †Equal contributions. ‡Equal contributions. Abstract BK polyomavirus has been linked to urothelial carcinoma in immunosuppressed patients. Here, we performed comprehensive genomic analysis of a BK polyomavirus-associated, metachronous, multifocal and metastatic micropapillary urothelial cancer in a kidney